Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no cure for debilitating neurological conditions like ...

The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.

Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

A UC San Diego-led team's project to develop next-generation brain implants builds on the development of this transparent ...

The 10-million mark was reached in 2020. In 2024 around 2.7 million procedures were done and the cumulative total is over 17 ...

After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...

The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...

“Baylen Out Loud” is back with season 1, episode 7 today, Monday, Feb. 24, at 9 p.m. Eastern on TLC. If you cut ties with ...

There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...

The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...